Amanote Research

Amanote Research

    RegisterSign In

Correction To: Langer Et Al., Menopausal Hormone Therapy for Primary Prevention: Why the USPSTF Is Wrong

Climacteric - United Kingdom
doi 10.1080/13697137.2017.1368915
Full Text
Open PDF
Abstract

Available in full text

Categories
MedicineGynecologyObstetrics
Date

August 30, 2017

Authors

Unknown

Publisher

Informa UK Limited


Related search

Hormone Therapy for Menopausal Symptoms

Clinical Nurse Specialist
ManagementLPNLeadershipAdvancedDiagnosisLVNAssessmentSpecialized Nursing
2004English

Hormone Therapy for Menopausal Symptoms

BMJ
2012English

Vaginal Hormone Therapy for Urogenital and Menopausal Symptoms

Seminars in Reproductive Medicine
GynecologyEndocrinologyReproductive MedicineMetabolismObstetricsPhysiologyDiabetes
2005English

Hormone Therapy for Primary Prevention of Chronic Conditions in Postmenopausal Women

JAMA - Journal of the American Medical Association
Medicine
2017English

Why Is It Wrong to Breach an ASBO?

SSRN Electronic Journal
2009English

Availability of Menopausal Hormone Therapy Products Worldwide

Maturitas
BiochemistryGynecologyGeneticsObstetricsMolecular Biology
2020English

Menopausal Hormone Therapy: Modern State of the Problem

Shidnoevropejskij zurnal vnutrisnoi ta simejnoi medicini
2019English

Menopausal Hormone Therapy and Breast Cancer: What Is the True Size of the Increased Risk?

British Journal of Cancer
Cancer ResearchOncology
2016English

Evolution of Menopausal Hormone Therapy: From Standard to Ultra-Low Doses

Medical Council
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy